Fund profile by ISIN IE00BL0L0H60
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Research First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation by ISIN IE00BL0L0H60, domicile Ireland, and 1-year price performance +59.1%.
ISINIE00BL0L0H60
TER—
DomicileIreland
Distribution policy—
Index—
Fund size14M
Holdings—
1-year price performance+59.1%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| FBT.MI | ETFP | EUR | Ireland | €80K | 2,960 |
| FBTU.L | LSE | USD | Ireland | €69K | 2,609 |
| FBT.L | LSE | GBX | Ireland | €29K | 1,091 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund has no German listing, so a German broker may not offer it, or may route the order to a foreign venue. As of 2026-08-28.
Largest holdings
The 10 largest holdings make up 36.73% of the fund. As of 2026-08-24.
| Holding | Symbol | Weight |
|---|---|---|
| Corcept Therapeutics Inc | CORT | 4.22% |
| Regeneron Pharmaceuticals Inc | REGN | 3.89% |
| NeoGenomics Inc | NEO | 3.67% |
| Halozyme Therapeutics Inc | HALO | 3.67% |
| Illumina Inc | ILMN | 3.65% |
| Amgen Inc | AMGN | 3.59% |
| BeOne Medicines Ltd ADR | ONC | 3.58% |
| Bruker Corp | BRKR | 3.54% |
| Incyte Corp | INCY | 3.47% |
| Biogen Inc | BIIB | 3.45% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.